Related Experiment Video
Updated: Apr 2, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
23.3K
Adaptive deep brain stimulation in Parkinson's disease.
1Department of Neurology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Parkinsonism & Related Disorders
|September 29, 2015
Summary
Adaptive Deep Brain Stimulation (aDBS) may overcome limitations of traditional Deep Brain Stimulation (DBS) for Parkinson
Area of Science:
- Neuroscience
- Biomedical Engineering
- Neurology
Background:
- Deep Brain Stimulation (DBS) is a standard Parkinson's disease (PD) treatment.
- Current DBS methods face limitations including side effects and battery drain.
- Non-specific neural suppression by DBS may reduce treatment efficacy.
Purpose of the Study:
- To explore adaptive DBS (aDBS) as a potential improvement over conventional DBS for PD.
- To discuss feedback signals and algorithms for aDBS in PD.
- To outline a roadmap for the clinical implementation of aDBS.
Main Methods:
- Review of existing literature on aDBS for Parkinson's disease.
- Discussion of feedback mechanisms (e.g., neural signals) for adaptive control.
- Analysis of stimulation algorithms for real-time adjustment.
Main Results:
- aDBS shows promise in initial studies for improving PD treatment.
- Potential to target pathological neural activity more precisely.
- Addresses limitations of conventional DBS, such as over-suppression of neural activity.
Conclusions:
- aDBS offers a promising alternative for Parkinson's disease management.
- Further research is needed to refine feedback signals and algorithms.
- A clear path towards clinical application of aDBS is proposed.
Related Concept Videos
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K

